 |
VOOZH | about |
|
VOOZH | about |
Content |
As TAdviser found out in early August 2025, the developer of software for medicine "RTK-Element" in 2024 received revenue in the amount of 2.13 billion rubles. This is 1616.1% more than in the previous year, when the figure was 123.87 million rubles.
The cost of sales on an annualized basis soared by 2463.4% - from 110.86 million rubles to 2.84 billion rubles. Commercial expenses are not indicated in the accounting documentation, and management expenses decreased by 6.7% - from 155.96 million rubles to 145.58 million rubles. Other revenues soared by 270.5% - from 11.28 million rubles to 41.77 million rubles. At the same time, other expenses decreased by about a quarter - from 2.75 million rubles to 2.03 million rubles.
Revenues from the sale of products, goods, works and services quadrupled year-on-year - from 691.96 million rubles to 2.88 billion rubles. Payments to suppliers (contractors) for raw materials, materials, works and services increased by 5.1% - from 731.72 million rubles to 768.97 million rubles. Expenses in connection with the remuneration of workers increased by about a third, amounting to 1.13 billion rubles against 853.66 million rubles in 2023.
At the end of 2024, RTK-Element recorded a gross loss of 716.11 million rubles. For comparison, a year earlier, gross profit of 13.01 million rubles was shown. The loss from sales on an annualized basis increased from 142.96 million rubles to 861.69 million rubles. Net loss amounted to 949.77 million rubles against losses of 206.9 million rubles in 2023.
As of December 31, 2024, receivables amounted to 235.91 million rubles. A year earlier, the amount of 81.51 million rubles was indicated. Thus, there was an increase of 189.4%. Accounts payable increased almost fivefold - from 221.69 million rubles to 1.06 billion rubles.[1]
On November 23, 2022, it became known about the creation of a joint venture (JV) by Rostelecom and the Element Laboratory - for the development of intelligent systems and digital services for compulsory health insurance (compulsory medical insurance ).
The joint venture was formed on the basis of RTK-Element LLC, which was established in December 2020 by structures affiliated with Rostelecom. According to Interfax, citing data from SPARK-Interfax, RT Labs, a member of Rostelecom, retained 51% of RTK-Element, and LLC Laboratory Element received 49 %.
The press service of Rostelecom confirmed to the agency the creation of a joint venture with the Element Laboratory and called this deal "the logical development of Rostelecom's digital health care cluster."
| The alienation of a 49% stake in the company is carried out in order to create a joint venture to accumulate competencies in the development of intelligent systems and comprehensive customer-centric digital services of compulsory health insurance, the press service of the state communications operator added. |
This is not Rostelecom's first healthcare project. Thus, the company, together with Rostec"" are developing a joint venture, Tsifromed"" which is a center of competence for the digitalization of health care at the federal and regional levels.
Laboratory Element, as stated on the official website of the company, is developing services for screening drug prescriptions "drugscreening," checking substances for entry into the "prohibited" WADA list, as well as a system for supporting medical decision-making and continuing medical education UpToDate. Among the clients of the company are RUSADA, the National Anti-Doping Agency of Belarus "NADA," NMII Neurosurgery named after ACOD. N.N. Burdenko, Moscow City Compulsory Medical Insurance Fund.
According to the Unified State Register of Legal Entities, by the end of November 2022, the company is 58.7% owned by Sergei Merkulov, 16.7% each by Alexei Soshnin and Damir Engalychev, and another 8% by Aleksei Solovyov.[2]
| 👁 Шестерня | The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |
